Market Report: E-cigarette Market Slightly Rises in South Korea

Aug.06.2022
Market Report: E-cigarette Market Slightly Rises in South Korea
Market report: Traditional cigarette market share decreases while e-cigarettes increase in South Korea, according to a new report.

The report titled "Market Report: South Korea - Traditional cigarette market shares continue to decline, while e-cigarettes witness slight growth" has been added to the archives of ResearchAndMarkets.com. While the report notes a decrease in smoking rates and an increase in the use of safer alternatives to tobacco, it highlights that pending legislation could have negative implications for the market.


A report indicates that South Korea's electronic cigarette imports and exports are expected to decline in 2021. It also notes that China is the most important import market and Russia is the main export destination. As online sales of e-liquids are banned in South Korea, physical electronic cigarette stores remain the primary sales point for these products.


A few years ago, South Korea was among the world's fastest-growing markets for e-cigarettes, attracting the attention of major international manufacturers such as Juul Labs. However, in 2020, the government urged the public not to use e-cigarettes, and the industry took a hit when the major convenience store chain GS25 stopped selling flavored e-cigarette products from Juul Labs and local company KT&G.


Following this, the South Korean army announced a ban on the use and possession of electronic devices in its bases, sending a clear message to the public about strict regulation of electronic cigarettes. Additionally, a CNBC article at the time explained that this move was significant as South Korea has a large military of approximately 600,000 soldiers, primarily consisting of men, and Korean men still rank among the highest smokers in the world. Click to see the original report link.


Statement:


This article is compiled from third-party information and is for industry exchange and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The translation of this article is solely intended for industry communications and research purposes.


Due to the limitations of our translation abilities, the translated article may not convey the exact same meaning as the original. Please refer to the original article for more accurate information.


2FIRSTS maintains complete alignment with the Chinese government on all statements and positions related to domestic, Hong Kong, Macau, Taiwan, and foreign issues.


The rights to compile information belong to the original media and authors, and if there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai
Russian Lawmaker Says Vape Circulation Licensing Will Be Regulated by Law in the Coming Months
Russian Lawmaker Says Vape Circulation Licensing Will Be Regulated by Law in the Coming Months
Alexander Tolmachev, deputy chairman of the Russian State Duma Committee on Youth Policy, said the issue of licensing vape circulation will be resolved at the legislative level in the coming months. He said a significant share of such products currently on the market are counterfeit, that their real nicotine concentration may be several times higher than stated, and that the composition of the liquid is unknown.
Mar.18 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Editorial says West Virginia’s HB 5437 “Vape Safety Act” goes too far, targeting residency and citizenship provisions
Editorial says West Virginia’s HB 5437 “Vape Safety Act” goes too far, targeting residency and citizenship provisions
A News and Sentinel editorial argues that West Virginia’s HB 5437, the “Vape Safety Act,” goes beyond reasonable regulation by adding provisions barring any part of a vape or smoke shop from being used as a residence and requiring owners to be U.S. citizens.
Feb.27 by 2FIRSTS.ai
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
The Volume Illusion: Measuring the Future of Nicotine with the Tools of the Past
As next-generation nicotine products become economically central rather than marginal, traditional volume-based metrics are increasingly unable to explain consumption, risk, and value. Units designed for a cigarette-based economy struggle to describe systems defined by delivery speed, pharmacokinetics, and adaptive user behavior. Drawing on financial reporting, regulation, and nicotine science, a fundamental question: can the future of nicotine still be measured using the tools of its past?
Feb.09 by Alan Zhao | 2Firsts Perspectives
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11